A mechanical pump can be life-saving for heart failure patients or it can cause dangerous complications. Doctors can do a better job at explaining the reasons some patients may want to opt out.
Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there's a twist involving an opioid addiction treatment.
The overdose antidote naloxone could soon be available in more public places. The Veterans Administration is adding it to its automated defibrillator cabinets. Other institutions are following suit.
Medevac helicopter companies are on the congressional radar, as a funding bill for the Federal Aviation Administration nears passage. Consumer protections against deceptive practices could become law.
After an accident in an all-terrain vehicle crushed a doctor's left arm, he was whisked by air ambulance to the closest trauma center for specialized care. Soon he was fighting over the $56,603 bill.
Scientists at Johns Hopkins have identified a brain region in monkeys that influences their desire to take big risks. When this area is inactivated, the monkeys tend to hedge their bets.
A Japanese research team made immature human eggs from stem cells that were derived from human blood. The technique brings scientists a step closer to being able to mass-produce human eggs.
A small study of teens who were conceived via assisted reproductive technology finds a significant number already have hypertension and premature "age-related changes" in their blood vessels.
Getting mental health treatment to inmates who need it requires money and unprecedented collaboration between state and county departments of criminal justice and social services. Is it working?